scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1028226522 |
P356 | DOI | 10.1203/PDR.0B013E318123F757 |
P698 | PubMed publication ID | 17622953 |
P2093 | author name string | Rong Wang | |
Andre Obenaus | |||
Beatriz Tone | |||
Hou Rou Tian | |||
Stephen Ashwal | |||
Jerome Badaut | |||
Alison Rasmussen | |||
P2860 | cites work | Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites | Q24311737 |
Correlation of cerebral hypoxic-ischemic T2 changes with tissue alterations in water content and protein extravasation | Q30643940 | ||
Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses | Q31047774 | ||
Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia | Q31962510 | ||
Volume expansion during neonatal intensive care: do we know what we are doing? | Q33198811 | ||
NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. | Q33896104 | ||
Binding of drugs to serum albumin (first of two parts) | Q34082487 | ||
Epidemiology of perinatal stroke | Q34468322 | ||
The albumin controversy | Q35869313 | ||
Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats | Q36735367 | ||
The antioxidants of human extracellular fluids | Q37931818 | ||
Hemodilution for cerebral ischemia | Q38198963 | ||
Albumin--an important extracellular antioxidant? | Q39628687 | ||
The antioxidant action of human extracellular fluids. Effect of human serum and its protein components on the inactivation of alpha 1-antiproteinase by hypochlorous acid and by hydrogen peroxide | Q42011048 | ||
A direct role for serum albumin in the cellular uptake of long-chain fatty acids | Q42107847 | ||
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results | Q42689955 | ||
Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats | Q43722578 | ||
Cortical devascularization: quantitative diffusion weighted magnetic resonance imaging and histological findings | Q43762466 | ||
Systemic fatty acid responses to transient focal cerebral ischemia: influence of neuroprotectant therapy with human albumin | Q44187177 | ||
Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats | Q44660986 | ||
Brain edema and cerebrovascular permeability during cerebral ischemia in rats | Q45288349 | ||
A new model of neonatal stroke: reversible middle cerebral artery occlusion in the rat pup. | Q46039670 | ||
Effects of viscosity and oxygen content on cerebral blood flow in ischemic and normal rat brain | Q48116745 | ||
Blood-brain barrier disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental focal cerebral ischemia | Q48127859 | ||
The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats | Q48399986 | ||
Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-prone spontaneously hypertensive rats | Q48416233 | ||
Serial magnetic resonance imaging in a rat pup filament stroke model | Q48459869 | ||
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis | Q48482907 | ||
Vulnerability to cerebral hypoxic-ischemic insult in neonatal but not in adult rats is in parallel with disruption of the blood-brain barrier | Q48594689 | ||
Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats | Q48619614 | ||
Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats | Q48863137 | ||
Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window | Q49076970 | ||
Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat. | Q49161928 | ||
Prevention of hypoxic-ischemic damage with dexamethasone is dependent on age and not influenced by fasting. | Q51590455 | ||
The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report | Q57756939 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | blood–brain barrier | Q221694 |
P304 | page(s) | 261-266 | |
P577 | publication date | 2007-09-01 | |
P1433 | published in | Pediatric Research | Q7159215 |
P1476 | title | Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke | |
P478 | volume | 62 |
Q30670310 | A review of current imaging methods used in stroke research |
Q37698934 | Experimental methods and transport models for drug delivery across the blood-brain barrier |
Q36165784 | Increase of arginase activity in old apolipoprotein-E deficient mice under Western diet associated with changes in neurovascular unit |
Q26998918 | Mechanisms of perinatal arterial ischemic stroke |
Q30712180 | Neuroimaging of stroke and ischemia in animal models |
Q34086176 | Polynitroxyl albumin and albumin therapy after pediatric asphyxial cardiac arrest: effects on cerebral blood flow and neurologic outcome |
Q38731361 | Predicting Transport of 3,5,6-Trichloro-2-Pyridinol Into Saliva Using a Combination Experimental and Computational Approach |
Q37337439 | Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury |
Q46264188 | Protective role of early aquaporin 4 induction against postischemic edema formation |
Q61865389 | The myth of the immature barrier systems in the developing brain: role in perinatal brain injury |
Search more.